Breaking News: OTC Markets Group Achieves Record Revenue Growth in Fourth Quarter and Full Year 2024!
Fourth Quarter and Full Year 2024 Highlights:
Gross revenues of $111.1 million for the year, up 1% versus 2023. Operating income of $32.2 million for the year, down 1% versus 2023. Operating profit margin of 29.9% for the year, versus 30.6% for 2023. Net income of $27.4 million for 2024, down 1% versus 2023, and GAAP diluted EPS of $2.26 versus $2.28 for 2023. Total cash returned to shareholders during 2024 of $29.5 million, comprised of dividends of $26.6 million and repurchases of common shares of $2.9 million, down 1% versus 2023. Announcing first quarter 2025 dividend of $0.18 per share. 567 OTCQX® and 1,050 OTCQB® companies at year-end. 43 graduates to a national securities exchange during 2024. 114 subscribers to OTC Link ECN as of year-end 2024, up 6 versus 2023. 141 unique OTC Link subscribers, up 5 versus 2023. Approximately 38,000 average daily trades during 2024, versus approximately 32,000 during 2023. Fourth-quarter gross revenues of $28.5 million, up 3% versus the prior year quarter. Fourth-quarter operating income of $8.8 million, flat versus the prior year quarter. Fourth-quarter operating profit margin of 31.6%, compared to 32.8% in the prior year quarter. OTC Markets Group announced that in July 2025, it will launch OTCIDTM – a Basic Reporting Market for companies that meet a minimal current information standard and provide management certification. The Pink Current Market will cease to exist. In September 2024, OTC Markets Group launched OTC OvernightTM, a new offering for overnight trading in OTC equity securities. In November 2024, OTC Markets Group launched MOON ATSTM, a new offering for overnight trading in NMS securities. NEW YORK, March 12, 2025 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced its financial results for the fourth quarter and full year 2024.
How this will affect me:
As a shareholder, this record revenue growth signals a positive outlook for the future of OTC Markets Group. The increase in revenues and the announcement of dividends mean potential returns for investors. The new offerings for overnight trading also provide more options for trading in OTC equity and NMS securities, potentially leading to increased liquidity and trading opportunities.
How this will affect the world:
The record revenue growth of OTC Markets Group reflects a healthy and growing market for U.S. and international securities. This growth can have a positive impact on the overall economy, signaling confidence in the markets and potentially attracting more investors and companies to participate. The launch of new offerings for overnight trading can also contribute to increasing accessibility and efficiency in trading securities.
Conclusion:
In conclusion, the achievement of record revenue growth by OTC Markets Group in the fourth quarter and full year of 2024 represents a significant milestone for the company and the market as a whole. The results indicate strength and stability in the securities trading industry, providing opportunities for investors and companies alike. The new offerings and changes announced by OTC Markets Group also demonstrate a commitment to innovation and meeting the evolving needs of market participants. Overall, the future looks promising for OTC Markets Group and the broader financial markets.
